Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aflatoxin B1 is suspected as an etiologic factor in the increased risk for primary
liver cancer
among workers in animal-feed processing plants in Denmark. Aflatoxin bound to serum albumin was therefore measured for feed-processing workers. Blood samples were collected immediately after vacation and after four weeks of work, and aflatoxin was quantified by competitive enzyme-linked immunosorbant assay. Seven of 45 individuals with an estimated exposure of 64 ng aflatoxin B1.d-1.kg-1 body weight were positive. Three positive workers had been unloading a cargo with an aflatoxin B1 level of 26 micrograms.kg-1 raw material. The exposure level correlated well with the job titles.
Dust
samples collected at different sites showed considerable variation in the amount of aflatoxin B1 (nondetectable to 8 micrograms.kg-1 dust). The exposure to aflatoxin B1 may only partially explain the increased risk of
liver cancer
.
...
PMID:Determination of exposure to aflatoxins among Danish workers in animal-feed production through the analysis of aflatoxin B1 adducts to serum albumin. 178 37
Asip is a mammalian homologue of polarity protein Par-3 of Caenorhabditis elegans and
Bazooka
of Drosophila melanogaster. Asip/Par-3/
Bazooka
are PDZ-motif containing proteins that localize asymmetrically to the cell periphery and play a pivotal role in cell polarity and asymmetric cell division. In the present study, we have cloned human asip cDNA and its splicing variants by 5'-RACE and RT-PCR using candidate human EST clones which have a high homology to rat asip cDNA. The full-length cDNA of human asip encodes a 1,353 aa protein exhibiting 88% similarity to the rat one. Human asip is a single copy gene consisting of at least 26 exons and localizing in human chromosome 10, band p11.2, with some extraordinarily long introns. All exon/intron boundary nucleotides conform to the "gt-ag" rule. Three main transcripts were detected by Northern blot analysis, and at least five variants, from alternative splicing and polyadenylation, have been identified by RT-PCR and liver cDNA library screening. Exon 17b deleted asip mRNAs expressed ubiquitously in normal human tissues, including liver, on RT-PCR analysis. However, they were absent from most human
liver cancer
cell lines examined. More interestingly, the expression of exon 17b deleted variants was down regulated in 52.6% (10/19) clinic specimens of human hepatocellular carcinomas (HCCs), compared with the surrounding nontumorous liver tissues from the same patients. The presence of various splicing transcripts, the variation of their distribution among different tissues and cells, and their differential expressions in human HCCs suggest that human Asip isoforms may function in different context.
...
PMID:Down-regulated expression of atypical PKC-binding domain deleted asip isoforms in human hepatocellular carcinomas. 1164 8
There is some evidence that chronic diseases, such as cancer and cardiovascular disease, may occur as a result of oxidative stress. Apple peels have high concentrations of phenolic compounds and may assist in the prevention of chronic diseases. Millions of pounds of waste apple peels are generated in the production of applesauce and canned apples in New York State each year. We proposed that a valuable food ingredient could be made using the peels of these apples if they could be dried and ground to a powder without large losses of phytochemicals. Rome Beauty apple peels were treated with citric acid dips, ascorbic acid dips, and blanches before being oven-dried at 60 degrees C. Only blanching treatments greatly preserved the phenolic compounds, and peels blanched for 10 s had the highest total phenolic content. Rome Beauty apple peels were then blanched for 10 s and dried under various conditions (oven-dried at 40, 60, or 80 degrees C, air-dried, or freeze-dried). The air-dried and freeze-dried apple peels had the highest total phenolic, flavonoid, and anthocyanin contents. On a fresh weight basis, the total phenolic and flavonoid contents of these samples were similar to those of the fresh apple peels.
Freeze
-dried peels had a lower water activity than air-dried peels on a fresh weight basis. The optimal processing conditions for the ingredient were blanching for 10s and freeze-drying. The process was scaled up, and the apple peel powder ingredient was characterized. The total phenolic content was 3342 +/- 12 mg gallic acid equivalents/100 g dried peels, the flavonoid content was 2299 +/- 52 mg catechin equivalents/100 g dried peels, and the anthocyanin content was 169.7 +/- 1.6 mg cyanidin 3-glucoside equivalents/100 g dried peels. These phytochemical contents were a significantly higher than those of the fresh apple peels if calculated on a fresh weight basis (p < 0.05). The apple peel powder had a total antioxidant activity of 1251 +/- 56 micromol vitamin C equivalents/g, similar to fresh Rome Beauty peels on a fresh weight basis (p > 0.05). One gram of powder had an antioxidant activity equivalent to 220 mg of vitamin C. The freeze-dried apple peels also had a strong antiproliferative effect on HepG(2)
liver cancer
cells with a median effective dose (EC(50)) of 1.88 +/- 0.01 mg/mL. This was lower than the EC(50) exhibited by the fresh apple peels (p < 0.05). Apple peel powder may be used in a various food products to add phytochemicals and promote good health.
...
PMID:Apple peels as a value-added food ingredient. 1261 4
Nuclear medicine procedures are the methods of choice for the assessment of the tracer kinetics in a volume over time. Fluorine-18 fluoro-deoxyglucose ((18)F-FDG) is primarily a marker of tumor viability and the kinetics of (18)F-FDG reflects major biological factors like angiogenesis and proliferation. The correct interpretation of (18)F- FDG tracer kinetics demands the knowledge about the association of quantitative positron emission tomography (PET) data and gene expression. The use of gene arrays is helpful to obtain expression data for a large number of genes from tissue samples. However, limited data are available about quantitative (18)F-FDG data and gene array results. Studies in primary
liver cancer
patients revealed that the (18)F-FDG uptake was associated with genes related to tumor cell adhesion and tumor invasion. We noted in patients with giant cell tumors a correlation of the (18)F-FDG uptake, as measured by the standardized uptake value (SUV) and the cell division cycle 2 (cdc2) gene expression. The effect of therapeutic interventions is dependent on the agent used for treatment. In gastrointestinal stromal tumors the change in (18)F-FDG uptake is most likely due to an antiproliferative effect. However, this may be different in other tumor types and for other treatment protocols, therefore dedicated studies of the (18)F-FDG kinetics and gene expression are needed. Based on the recent data available in colorectal tumors and gene expression, we were able to demonstrate that at least two key genes of the angiogenesis, vascular endothelial growth factor (VEGF-A) and angiopoietin-2, have a major impact on the tracer kinetics. Furthermore, regression functions for the (18)F-FDG kinetics and gene expression data facilitate the calculation of parametric images of the gene expression, reflecting the spatial distribution of angiogenesis in a colorectal tumor. Currently the development of information management systems for the prediction of clinical relevant information in individual patients is in progress to retrieve the optimum on information from individual (18)F-FDG patient examinations to support individualization of treatment management.
Hell
J Nucl Med
PMID:The impact of gene expression on 18F-FDG kinetics; a new chapter for diagnostic nuclear medicine. 1933 Jan 72
We investigated the leaves of Kleinhovia hospita, a plant which has been traditionally used in Indonesia as phytotherapy to cure liver disease, to describe antioxidant materials from plant sources. K. hospita leaves were extracted with methanol and further partitioned into n-hexane, diethyl ether, and ethyl acetate. The antioxidant activity of each fraction and the residue was assessed using a 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method and their cytotoxicity on HepG2
liver cancer
cells was determined by a MTT assay. The K. hospita leaf methanol extract showed strong antioxidant activity (96%) compared with vitamin C (98%) by the DPPH method and the measured activity from the subsequent extracts of the methanol extract were 48.9% for n-hexane, 74.0% for diethyl ether, 84.3% for ethyl acetate, and 77.1% for the residue. The MTT assay showed the cytotoxicity of the methanol extract on HepG2 cells at 14%, 76%, and 80% at concentrations of 50 microg/mL, 87.5 microg/mL, and 125 microg/mL, respectively.
Leaf
extracts of the medicinal plant K. hospita showed potent antioxidant activity and moderate cytotoxicity on HepG2
liver cancer
cells.
...
PMID:Antioxidant activity and cytotoxicity of the traditional Indonesian medicine Tahongai (Kleinhovia hospita L.) extract. 2063 7
Epimedium pseudowushanense
B.L.Guo is used in traditional medicine as an aphrodisiac and to strengthen muscles and bones. Several recent reports have shown that flavonoids from
Epimedium
also significantly affect the treatment of breast cancer,
liver cancer
, and leukemia. However, few studies have examined the medicinal-ingredient yield of
Epimedium
, a light-demanding shade herb, under different light intensities. To investigate the effects of light intensity on medicinal-ingredient yields,
Epimedium
was exposed to five levels of light intensity until harvest time.
Leaf
dry biomass under L4 was the highest among different light treatments. L4 was also associated with the highest net photosynthetic rate. Quantification of epimedin A, epimedin B, epimedin C, and icariin showed that L3 produced the highest amount of epimedin C, and that flavonoid content responded to light levels differently. Results indicated that L3 and L4 were the optimal light levels for medicinal-ingredient yield.
...
PMID:Effects of Light Intensity on the Growth, Photosynthetic Characteristics, and Flavonoid Content of Epimedium pseudowushanense B.L.Guo. 2782 37
TNF-related apoptosis-inducing ligand (TRAIL) possesses the capacity to induce apoptosis in a wide variety of tumor cells without affecting most normal cells. However, it has now emerged that many primary cancer cells are resistant to TRAIL monotherapy. Overcoming the intrinsic or acquired TRAIL resistance is desirable for TRAIL-mediated cancer therapy. In this study, we found that the miR-221/222 cluster was up-regulated in TRAIL-resistant
liver cancer
cells. Specific inhibitors of miR-221 and/or miR-222, called sponge, TuD and miR-
Zip
were constructed, and their ability to overcome TRAIL resistance was compared. Among them, AAV-mediated gene therapy using co-expression of TRAIL with miR-221-
Zip
showed the most synergistic activity in the induction of apoptosis
in vitro
.
In vivo
treatment of nude mice bearing human TRAIL-resistant
liver cancer
xenografts with AAV-TRAIL-miR-221-
Zip
also led to growth inhibition. This sensitizing effect of miR-221-
Zip
was associated with increased expression of PTEN, the miR-221 target, as well as with decreasing levels of Survivin. Moreover, miR-221 expression was concomitant with promotion of Survivin expression and suppression of PTEN expression. TRAIL sensitivity of cancer cells isolated from
liver cancer
tissues or from patients was significantly correlated with miR-221 expression. And miR-221 blood expression levels in
liver cancer
patients were correlated with TRAIL sensitivity, thus it had the potential to be a predictor of TRAIL sensitivity in
liver cancer
. These data suggested the potential of combining AAV-TRAIL with miR-221-
Zip
as a therapeutic intervention for
liver cancer
.
...
PMID:Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer. 2890 May 6